Regulatory T cells and human disease

S Sakaguchi, N Mikami, JB Wing… - Annual review of …, 2020 - annualreviews.org
Naturally occurring CD4+ regulatory T cells (Tregs), which specifically express the
transcription factor FoxP3 in the nucleus and CD25 and CTLA-4 on the cell surface, are a …

Targeting Treg cells in cancer immunotherapy

A Tanaka, S Sakaguchi - European journal of immunology, 2019 - Wiley Online Library
Foxp3‐expressing regulatory T (Treg) cells, which are indispensable for preventing
autoimmunity, also suppress effective tumor immunity. Treg cells abundantly infiltrate into …

Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity

B Weigelin, AT den Boer, E Wagena, K Broen… - Nature …, 2021 - nature.com
Lethal hit delivery by cytotoxic T lymphocytes (CTL) towards B lymphoma cells occurs as a
binary,“yes/no” process. In non-hematologic solid tumors, however, CTL often fail to kill …

CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19

V Mallajosyula, C Ganjavi, S Chakraborty… - Science …, 2021 - science.org
A central feature of the SARS-CoV-2 pandemic is that some individuals become severely ill
or die, whereas others have only a mild disease course or are asymptomatic. Here, we …

[PDF][PDF] Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer

JB Wing, A Tanaka, S Sakaguchi - Immunity, 2019 - cell.com
Regulatory T (Treg) cells expressing the transcription factor Foxp3 have a critical role in the
maintenance of immune homeostasis and prevention of autoimmunity. Recent advances in …

CTLA-4: a moving target in immunotherapy

B Rowshanravan, N Halliday… - Blood, The Journal of …, 2018 - ashpublications.org
CD28 and CTLA-4 are members of a family of immunoglobulin-related receptors that are
responsible for various aspects of T-cell immune regulation. The family includes CD28 …

Regulatory T cells in cancer immunotherapy

A Tanaka, S Sakaguchi - Cell research, 2017 - nature.com
FOXP3-expressing regulatory T (Treg) cells, which suppress aberrant immune response
against self-antigens, also suppress anti-tumor immune response. Infiltration of a large …

A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy

M Łuksza, N Riaz, V Makarov, VP Balachandran… - Nature, 2017 - nature.com
Checkpoint blockade immunotherapies enable the host immune system to recognize and
destroy tumour cells. Their clinical activity has been correlated with activated T-cell …

The multiple pathways to autoimmunity

AN Theofilopoulos, DH Kono, R Baccala - Nature immunology, 2017 - nature.com
Efforts to understand autoimmunity have been pursued relentlessly for several decades. It
has become apparent that the immune system evolved multiple mechanisms for controlling …

Targeting co-stimulatory molecules in autoimmune disease

NM Edner, G Carlesso, JS Rush… - Nature Reviews Drug …, 2020 - nature.com
Therapeutic targeting of immune checkpoints has garnered significant attention in the area
of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T …